Correlation Between Precision BioSciences and Enanta Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Precision BioSciences and Enanta Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Precision BioSciences and Enanta Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Precision BioSciences and Enanta Pharmaceuticals, you can compare the effects of market volatilities on Precision BioSciences and Enanta Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Precision BioSciences with a short position of Enanta Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Precision BioSciences and Enanta Pharmaceuticals.
Diversification Opportunities for Precision BioSciences and Enanta Pharmaceuticals
0.95 | Correlation Coefficient |
Almost no diversification
The 3 months correlation between Precision and Enanta is 0.95. Overlapping area represents the amount of risk that can be diversified away by holding Precision BioSciences and Enanta Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Enanta Pharmaceuticals and Precision BioSciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Precision BioSciences are associated (or correlated) with Enanta Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Enanta Pharmaceuticals has no effect on the direction of Precision BioSciences i.e., Precision BioSciences and Enanta Pharmaceuticals go up and down completely randomly.
Pair Corralation between Precision BioSciences and Enanta Pharmaceuticals
Given the investment horizon of 90 days Precision BioSciences is expected to generate 2.97 times more return on investment than Enanta Pharmaceuticals. However, Precision BioSciences is 2.97 times more volatile than Enanta Pharmaceuticals. It trades about 0.08 of its potential returns per unit of risk. Enanta Pharmaceuticals is currently generating about -0.15 per unit of risk. If you would invest 460.00 in Precision BioSciences on October 20, 2024 and sell it today you would earn a total of 36.00 from holding Precision BioSciences or generate 7.83% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Strong |
| Accuracy | 95.0% |
| Values | Daily Returns |
Precision BioSciences vs. Enanta Pharmaceuticals
Performance |
| Timeline |
| Precision BioSciences |
| Enanta Pharmaceuticals |
Precision BioSciences and Enanta Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Precision BioSciences and Enanta Pharmaceuticals
The main advantage of trading using opposite Precision BioSciences and Enanta Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Precision BioSciences position performs unexpectedly, Enanta Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Enanta Pharmaceuticals will offset losses from the drop in Enanta Pharmaceuticals' long position.| Precision BioSciences vs. X4 Pharmaceuticals | Precision BioSciences vs. Acumen Pharmaceuticals | Precision BioSciences vs. Inozyme Pharma | Precision BioSciences vs. Terns Pharmaceuticals |
| Enanta Pharmaceuticals vs. Monte Rosa Therapeutics | Enanta Pharmaceuticals vs. Design Therapeutics | Enanta Pharmaceuticals vs. Werewolf Therapeutics | Enanta Pharmaceuticals vs. Ikena Oncology |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Other Complementary Tools
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format |